<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02061826</url>
  </required_header>
  <id_info>
    <org_study_id>Ditan-2014-01</org_study_id>
    <nct_id>NCT02061826</nct_id>
  </id_info>
  <brief_title>Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)</brief_title>
  <official_title>Establishment of Drug-induced Liver Injury Databases and Application of Circulating miRNA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Ditan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Ditan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to establish drug-induced liver injury databases in China, make&#xD;
      criteria for Chinese drug-induced liver injury patients and evaluate the application of&#xD;
      certain circulating miRNA in diagnosis or treatment of drug-induced liver injury.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Firstly, this study collects some retrospective data. Analyse these data and establish&#xD;
      certain unique diagnostic criteria for Chinese. Then collect prospective data and validate&#xD;
      the criteria. Otherwise,collect blood sample or other sample of the patients and study&#xD;
      certain miRNA in diagnosis or treatment of drug-induced liver injury.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>histological features of drug-induced liver injury obtained by liver biopsy</measure>
    <time_frame>within six months of the DILI onset date</time_frame>
    <description>Liver biopsy is the main method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical features of drug-induced liver injury assessed by serum parameters of liver function</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 3 weeks</time_frame>
    <description>serum parameters of liver function is the focus</description>
  </primary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Drug-induced Liver Injury</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum,plasma,PBMC&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        community sample and primary care clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females between the age of 18 to 70 years&#xD;
&#xD;
          -  Women in child-bearing period taking some contraception measures&#xD;
&#xD;
          -  Patients with onset of acute liver injury attributed to antituberculosis drugs or&#xD;
             antineoplastic drugs, Roussel Uclaf Causality Assessment Method（RUCAM ） score≥6&#xD;
&#xD;
          -  Written informed consent can be obtained, some patients agree with liver biopsy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Viral hepatitis&#xD;
&#xD;
          -  Alcoholic liver disease or non-alcoholic liver disease&#xD;
&#xD;
          -  Wilson's disease or other inherited metabolic liver diseases&#xD;
&#xD;
          -  Auto-immune liver diseases&#xD;
&#xD;
          -  Any dysfunction of liver&#xD;
&#xD;
          -  Malnutrition&#xD;
&#xD;
          -  Chronic diseases such as HIV,severe heart diseases, severe brain diseases or chronic&#xD;
             kidney diseases&#xD;
&#xD;
          -  Patients who can not complete follow-ups on time&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wen Xie, master</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Ditan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wen Xie, master</last_name>
    <phone>+86 84322816</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Ditan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100015</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Hong Zhao, master</last_name>
      <phone>+86 84322816</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <study_first_submitted>January 26, 2014</study_first_submitted>
  <study_first_submitted_qc>February 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2014</study_first_posted>
  <last_update_submitted>February 15, 2014</last_update_submitted>
  <last_update_submitted_qc>February 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Ditan Hospital</investigator_affiliation>
    <investigator_full_name>Wen Xie</investigator_full_name>
    <investigator_title>head of department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chemical and Drug Induced Liver Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

